We are live on ! Find out more
SFG

SVB Financial Group Portfolio holdings

AUM $434K
1-Year Est. Return 277.67%
This Fund
S&P 500
This Quarter Est. Return
+6.69%
1 Year Est. Return
+277.67%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$53.2M
AUM Growth
+$251K
Cap. Flow
-$2.7M
Cap. Flow %
-5.07%
Top 10 Hldgs %
98.52%
Holding
24
New
–
Increased
1
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
FIRY
Firy Inc
FIRY
+$2.25K

Top Sells

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$1.57M
2
DICE
DICE Therapeutics, Inc. Common Stock
DICE
+$1.01M
3
PRDS
Pardes Biosciences, Inc. Common Stock
PRDS
+$65K
4
KLRS
Kalaris Therapeutics
KLRS
+$25.5K
5
GBIO
Generation Bio
GBIO
+$13.5K

Sector Composition

Rank Sector Weight
1 Financials 71.48%
2 Healthcare 13.72%
3 Technology 12.19%
4 Consumer Discretionary 1.63%
5 Industrials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COIN icon
1
Coinbase
COIN
$39.5B
$30.6M 57.48%
406,973
– –
ROOT icon
2
Root
ROOT
$954M
$7.45M 14.01%
783,012
– –
OKTA icon
3
Okta
OKTA
$25.6B
$6.45M 12.14%
79,152
-20,720
-21% -$1.57M
AXSM icon
4
Axsome Therapeutics
AXSM
$11B
$2.37M 4.45%
33,849
– –
GPCR icon
5
Structure Therapeutics
GPCR
$3.59B
$1.78M 3.35%
35,353
– –
OBIO icon
6
Orchestra BioMed
OBIO
$253M
$1.11M 2.08%
127,068
– –
MLTX icon
7
MoonLake Immunotherapeutics
MLTX
$1.49B
$922K 1.73%
16,173
– –
ROVR
8
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
$661K 1.24%
105,534
– –
CMAX
9
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$636K 1.2%
10,000
– –
PL icon
10
Planet Labs
PL
$7.97B
$447K 0.84%
172,097
– –
GLBE icon
11
Global E Online
GLBE
$6.98B
$203K 0.38%
5,114
– –
CGEM icon
12
Cullinan Oncology
CGEM
$1.08B
$122K 0.23%
13,516
– –
CRBU icon
13
Caribou Biosciences
CRBU
$160M
$99K 0.19%
20,714
– –
GBIO
14
DELISTED
Generation Bio
GBIO
$94.9K 0.18%
2,503
-285
-10% -$13.5K
PACB icon
15
Pacific Biosciences
PACB
$404M
$85.6K 0.16%
10,249
– –
FIRY
16
Firy Inc
FIRY
$154M
$71.1K 0.13%
13,950
+254
+2% +$2.25K
KLRS
17
Kalaris Therapeutics
KLRS
$99.7M
$37K 0.07%
748
-374
-33% -$25.5K
MVLA
18
DELISTED
Movella Holdings Inc. Common Stock
MVLA
$29.8K 0.06%
55,528
– –
VERO
19
DELISTED
Venus Concept
VERO
$20.9K 0.04%
970
– –
ELDN icon
20
Eledon Pharmaceuticals
ELDN
$266M
$18.5K 0.03%
13,472
-4,553
-25% -$6.08K
MKUL
21
DELISTED
Molekule Group, Inc. Common Stock
MKUL
$3.08K 0.01%
21,247
– –
PRDS
22
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
– –
-35,923
Closed -$65K
DICE
23
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
– –
-21,799
Closed -$1.01M
GRNA
24
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
– –
-16,950
Closed -$5.08K

Similar funds

RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
CBFP
Cedar Brook Financial Partners Cleveland, Ohio $698K AUM 46.64% 1-Year Est. Return
BP
BFAM Partners Northpoint, Hong Kong, Hong Kong $44K AUM 8.69% 1-Year Est. Return
SLA
SWaN & Legend Advisors Leesburg, Virginia $841K AUM 23.47% 1-Year Est. Return
SG
Stagwell Group Miami Beach, Florida $913K AUM 49.68% 1-Year Est. Return
AFG
AFS Financial Group Bethesda, Maryland $1.15M AUM 23.97% 1-Year Est. Return
K
Kemper Chicago, Illinois $1.2M AUM 20.64% 1-Year Est. Return
MIG
MGG Investment Group New York $1.36M AUM 20.76% 1-Year Est. Return

SVB Financial Group's Q3 2023 Portfolio in Review

As of Q3 2023, SVB Financial Group held 24 positions worth $53.2M, up 0.47% from $52.9M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

SVB Financial Group withdrew a net $2.7M in Q3 2023, closing 3 positions and reducing 4 holdings. Its most notable exit was DICE Therapeutics, Inc. Common Stock, an estimated $1.01M position sold in full.

By sector, the portfolio is most concentrated in Financials at 71% of assets, up from 68% a quarter earlier, followed by Healthcare and Technology.

Against the trend, SVB Financial Group added an estimated $2.25K to Firy Inc.

  • SVB Financial Group added most to Firy Inc in Q3 2023, an estimated $2.25K increase.
  • SVB Financial Group's biggest Q3 2023 reduction was Okta, cutting an estimated $1.57M.
  • SVB Financial Group fully exited DICE Therapeutics, Inc. Common Stock in Q3 2023, selling an estimated $1.01M.
  • SVB Financial Group's ten largest holdings make up 99% of its $53.2M portfolio in Q3 2023.
  • SVB Financial Group opened 0 new positions and closed 3 in Q3 2023.
  • SVB Financial Group's portfolio value rose 0.47% quarter-over-quarter to $53.2M.

Based on SVB Financial Group's 13F filing for Q3 2023, filed 14 Nov 2023.